Hillhouse Capital Management - Q3 2017 holdings

$6.05 Billion is the total value of Hillhouse Capital Management's 48 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 43.3% .

 Value Shares↓ Weighting
JD SellJD COM INCspon adr cl a$2,154,319,000
-17.9%
56,395,797
-15.7%
35.59%
-12.0%
BABA  ALIBABA GROUP HLDG LTDsponsored ads$616,652,000
+22.6%
3,570,4490.0%10.19%
+31.4%
ESGR BuyENSTAR GROUP LIMITED$433,631,000
+24.7%
1,950,218
+11.4%
7.16%
+33.7%
BGNE BuyBEIGENE LTDsponsored adr$403,161,000
+140.8%
3,896,782
+4.7%
6.66%
+158.1%
WUBA  58 COM INCspon adr rep a$350,455,000
+43.1%
5,550,4510.0%5.79%
+53.4%
MDLZ SellMONDELEZ INTL INCcl a$332,182,000
-13.1%
8,169,741
-7.7%
5.49%
-6.9%
MLCO  MELCO RESORT ENTERTAINMENT Ladr$215,308,000
+7.4%
8,926,5460.0%3.56%
+15.2%
PCLN SellPRICELINE GRP INC$205,678,000
-56.9%
112,342
-56.0%
3.40%
-53.8%
FGEN BuyFIBROGEN INC$133,757,000
+136.6%
2,486,196
+42.1%
2.21%
+153.7%
TAL BuyTAL ED GROUPsponsored ads$121,138,000
+65.4%
3,593,520
+500.0%
2.00%
+77.2%
NTES BuyNETEASE INCsponsored adr$118,355,000
+294.3%
448,637
+349.3%
1.96%
+322.2%
BEDU  BRIGHT SCHOLAR ED HLDGS LTDsponsored ads$99,889,000
+95.2%
4,300,0000.0%1.65%
+109.1%
SOHU  SOHU COM INC$89,882,000
+20.8%
1,650,7270.0%1.48%
+29.6%
SNAP NewSNAP INCcl a$88,793,0006,106,810
+100.0%
1.47%
SINA SellSINA CORPord$78,474,000
-35.0%
684,466
-51.8%
1.30%
-30.3%
TRIP  TRIPADVISOR INC$66,176,000
+6.1%
1,632,7570.0%1.09%
+13.7%
CBPO NewCHINA BIOLOGIC PRODS HLDGS I$57,059,000618,391
+100.0%
0.94%
BITA  BITAUTO HLDGS LTDsponsored ads$50,221,000
+55.4%
1,124,0170.0%0.83%
+66.7%
YY BuyYY INC$46,766,000
+127.0%
538,906
+51.8%
0.77%
+143.1%
BPMC BuyBLUEPRINT MEDICINES CORP$41,722,000
+41.2%
598,849
+2.7%
0.69%
+51.1%
VIPS BuyVIPSHOP HLDGS LTDsponsored adr$34,716,000
+4077.6%
3,949,523
+4913.0%
0.57%
+4315.4%
XLRN  ACCELERON PHARMA INC$26,124,000
+22.8%
700,0000.0%0.43%
+31.7%
LBTYK BuyLIBERTY GLOBAL PLC$24,935,000
+89.1%
762,544
+80.3%
0.41%
+103.0%
TWTR  TWITTER INC$18,878,000
-5.6%
1,119,0000.0%0.31%
+1.3%
CHTR  CHARTER COMMUNICATIONS INC Ncl a$18,027,000
+7.9%
49,6030.0%0.30%
+15.5%
BRKA BuyBERKSHIRE HATHAWAY INC DELcl a$17,583,000
+15.1%
64
+6.7%
0.29%
+23.3%
KANG NewIKANG HEALTHCARE GROUP INCsponsored adr$16,996,0001,260,798
+100.0%
0.28%
ITCI  INTRA CELLULAR THERAPIES INC$15,780,000
+27.1%
1,000,0000.0%0.26%
+36.6%
SCHW  SCHWAB CHARLES CORP NEW$14,862,000
+1.8%
339,7820.0%0.25%
+9.3%
MCO  MOODYS CORP$12,522,000
+14.4%
89,9490.0%0.21%
+22.5%
VRSN  VERISIGN INC$12,476,000
+14.4%
117,2640.0%0.21%
+22.6%
RYB NewRYB ED INCadr$12,255,000430,000
+100.0%
0.20%
LN  LINE CORPsponsored adr$12,192,000
+4.1%
336,8000.0%0.20%
+11.0%
NFLX NewNETFLIX INC$12,096,00066,700
+100.0%
0.20%
TIG  TIGENIXsponsored ads$11,545,000
+5.8%
483,8700.0%0.19%
+13.7%
GTHX  G1 THERAPEUTICS INC$11,201,000
+42.7%
450,0000.0%0.18%
+52.9%
AMZN  AMAZON COM INC$11,115,000
-0.7%
11,5620.0%0.18%
+6.4%
CCJ  CAMECO CORP$9,919,000
+6.3%
1,025,7000.0%0.16%
+13.9%
SPGI  S&P GLOBAL INC$9,095,000
+7.1%
58,1870.0%0.15%
+14.5%
MYOK NewMYOKARDIA INC$8,236,000192,213
+100.0%
0.14%
CLSD  CLEARSIDE BIOMEDICAL INC$7,866,000
-4.1%
900,0000.0%0.13%
+3.2%
NewNABRIVA THERAPEUTICS PLC$6,570,000802,174
+100.0%
0.11%
IDXX BuyIDEXX LABS INC$6,488,000
+39.4%
41,725
+44.8%
0.11%
+48.6%
SFUN  FANG HLDGS LTDadr$6,075,000
+9.2%
1,500,0000.0%0.10%
+16.3%
TSRO BuyTESARO INC$4,790,000
+15.3%
37,100
+24.9%
0.08%
+23.4%
SNDX SellSYNDAX PHARMACEUTICALS INC$2,703,000
-21.2%
231,033
-5.9%
0.04%
-15.1%
JNCE  JOUNCE THERAPEUTICS INC$2,025,000
+11.0%
130,0000.0%0.03%
+17.9%
PTI  PROTEOSTASIS THERAPEUTICS IN$1,818,000
-55.1%
865,9230.0%0.03%
-51.6%
LC ExitLENDINGCLUB CORP$0-100,000
-100.0%
-0.01%
XNET ExitXUNLEI LTDsponsored adr$0-403,041
-100.0%
-0.02%
MRTX ExitMIRATI THERAPEUTICS INC$0-725,000
-100.0%
-0.04%
BHVN ExitBIOHAVEN PHARMACTL HLDG CO L$0-120,000
-100.0%
-0.05%
PYPL ExitPAYPAL HLDGS INC$0-75,186
-100.0%
-0.06%
PRTA ExitPROTHENA CORP PLC$0-75,000
-100.0%
-0.06%
TBPH ExitTHERAVANCE BIOPHARMA INC$0-122,856
-100.0%
-0.08%
ACIU ExitAC IMMUNE SA$0-550,000
-100.0%
-0.08%
ADAP ExitADAPTIMMUNE THERAPEUTICS PLCsponds adr$0-1,190,476
-100.0%
-0.08%
URGN ExitUROGEN PHARMA LTD$0-352,300
-100.0%
-0.10%
NBRV ExitNABRIVA THERAPEUTICS AGsponsored adr$0-686,400
-100.0%
-0.11%
V ExitVISA INC$0-92,100
-100.0%
-0.13%
FB ExitFACEBOOK INCcl a$0-60,300
-100.0%
-0.14%
WB ExitWEIBO CORPsponsored adr$0-142,020
-100.0%
-0.14%
CBPO ExitCHINA BIOLOGIC PRODS INC$0-753,624
-100.0%
-1.31%
YUMC ExitYUM CHINA HLDGS INC$0-2,302,989
-100.0%
-1.40%
MOMO ExitMOMO INCadr$0-2,629,062
-100.0%
-1.50%
ZTO ExitZTO EXPRESS CAYMAN INCsponsored adr$0-11,386,920
-100.0%
-2.45%
CTRP ExitCTRIP COM INTL LTD$0-4,812,246
-100.0%
-4.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MONDELEZ INTL INC22Q3 201844.4%
JD COM INC19Q2 201980.2%
SOHU COM INC19Q1 201813.4%
58 COM INC18Q3 20187.8%
TAL EDUCATION GROUP18Q2 20194.4%
CTRIP COM INTL LTD17Q2 201728.4%
BEIGENE LTD14Q2 201925.2%
MELCO RESORT ENTERTAINMENT L14Q3 20186.4%
CAMECO CORP14Q4 20172.2%
ENSTAR GROUP LIMITED12Q2 201921.9%

View Hillhouse Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Hillhouse Capital Management Q3 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
China Jo-Jo Drugstores Holdings, Inc.February 14, 2023403,3344.7%
TScan Therapeutics, Inc.February 14, 2023? ?
Enfusion, Inc.February 14, 20224,975,1837.6%
Enstar Group LTDJuly 19, 2021? ?
Zoom Video Communications, Inc.February 16, 20212,981,2651.5%
NIO Inc.February 14, 2020? ?
Sea LtdFebruary 14, 20204,300,0002.3%
Uxin LtdFebruary 14, 202021,733,0232.6%
Apellis Pharmaceuticals, Inc.February 14, 20192,098,5813.7%
iQIYI, Inc.February 14, 2019240,191,17411.0%

View Hillhouse Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-03-05
13F-NT2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
42024-02-01
32024-01-25
13F-NT2023-11-14
13F-NT2023-08-14

View Hillhouse Capital Management's complete filings history.

Compare quarters

Export Hillhouse Capital Management's holdings